monoclonal antibodies

Symptomatic rabies has no cure, but recent advances in rabies structural biology and antibody cocktails point to better treatments on the horizon.

The Alzheimer's disease research field has been beset by failed clinical trials and fraud. But researchers remain hopeful that a better understanding of the disease’s broader picture will lead to treatments.

LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.

Yurogen and Asuragen acquisitions expected to aid wide range of researchers

Immunotherapy is typically thought of in the context of cancer treatment, but many of the same therapies used to activate the immune system to treat cancer may also combat infectious diseases.

Inhalable Antibodies for SARS-CoV-2

Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply.  

Tiziana and Parexel will conduct Phase 1b/2 study of take-home capsules of Foralumab, an anti-CD3 monoclonal antibody